Precise guided radiation therapy for kidney cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new type of precise radiation therapy for kidney cancer. It uses a special scanner to guide the treatment without needing a marker, which may make the procedure quicker and more comfortable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have kidney cancer (confirmed by biopsy or strongly suspected from scans).
- The cancer must not have spread to other parts of your body (no metastases).
- You need to be 18 years or older.
- You must be able to understand the study and sign a consent form.
- You cannot have had high-dose radiation to the kidney area before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of radiation therapy that targets kidney cancer cells. It is for people whose cancer has returned or spread after at least two prior treatments, and aims to see if it can shrink tumors and slow the disease.
This trial uses a precise, high-dose radiation technique (called stereotactic body radiation therapy) that tracks and treats kidney tumors while you breathe. It aims to destroy tumors without surgery, potentially offering a less invasive option for people who cannot or prefer not to have an operation.
This trial uses two types of PET scans to better target radiation therapy in patients with advanced clear cell kidney cancer that has spread or returned. The goal is to combine radiation with standard drug treatments to improve outcomes.
This trial tests a new way to deliver radiation to kidney tumors using MRI guidance. It aims to treat early-stage kidney cancer while sparing healthy tissue, and may be an option for people who cannot have surgery or prefer not to.
This trial tests a precise type of radiation called stereotactic body proton therapy for people with kidney cancer who cannot have surgery or other local treatments. It aims to see if this focused radiation can control the tumor with fewer side effects.
This trial tests a precise type of radiation therapy for small, early-stage kidney tumors that cannot be surgically removed or are at high risk for surgery. It aims to offer an alternative treatment with fewer side effects.
Hear when a new Renal Cell Carcinoma (RCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.